Kazia Enters Clinical Collaboration for Metastatic Brain Cance...
SYDNEY, May 20, 2019 /PRNewswire-AsiaNet/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that it has entered into a collaboration with the Alliance for Clinical Trials in Oncology Foundation (Alliance), a U...
Authors: LATEST ASIANET NEWS RELEASES